Abstract:BackgroundFibroblastic foci are characteristic features in lung parenchyma of patients with idiopathic pulmonary fibrosis (IPF). They comprise aggregates of mesenchymal cells which underlie sites of unresolved epithelial injury and are associated with progression of fibrosis. However, the cellular origins of these mesenchymal phenotypes remain unclear. We examined whether the potent fibrogenic cytokine TGF-β1 could induce epithelial mesenchymal transition (EMT) in the human alveolar epithelial cell line, A549, and investigated the signaling pathway of TGF-β1-mediated EMT.MethodsA549 cells were examined for evidence of EMT after treatment with TGF-β1. EMT was assessed by: morphology under phase-contrast microscopy; Western analysis of cell lysates for expression of mesenchymal phenotypic markers including fibronectin EDA (Fn-EDA), and expression of epithelial phenotypic markers including E-cadherin (E-cad). Markers of fibrogenesis, including collagens and connective tissue growth factor (CTGF) were also evaluated by measuring mRNA level using RT-PCR, and protein by immunofluorescence or Western blotting. Signaling pathways for EMT were characterized by Western analysis of cell lysates using monoclonal antibodies to detect phosphorylated Erk1/2 and Smad2 after TGF-β1 treatment in the presence or absence of MEK inhibitors. The role of Smad2 in TGF-β1-mediated EMT was investigated using siRNA.ResultsThe data showed that TGF-β1, but not TNF-α or IL-1β, induced A549 cells with an alveolar epithelial type II cell phenotype to undergo EMT in a time-and concentration-dependent manner. The process of EMT was accompanied by morphological alteration and expression of the fibroblast phenotypic markers Fn-EDA and vimentin, concomitant with a downregulation of the epithelial phenotype marker E-cad. Furthermore, cells that had undergone EMT showed enhanced expression of markers of fibrogenesis including collagens type I and III and CTGF. MMP-2 expression was also evidenced. TGF-β1-induced EMT occurred through phosphorylation of Smad2 and was inhibited by Smad2 gene silencing; MEK inhibitors failed to attenuate either EMT-associated Smad2 phosphorylation or the observed phenotypic changes.ConclusionOur study shows that TGF-β1 induces A549 alveolar epithelial cells to undergo EMT via Smad2 activation. Our data support the concept of EMT in lung epithelial cells, and suggest the need for further studies to investigate the phenomenon.

Roles of p38 MAPK and JNK in TGF-β1-induced alveolar epithelial to mesenchymal transition

Roles of p38 MAPK and JNK in TGF-β1-induced human alveolar epithelial to mesenchymal transition.

TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT)

Epithelial-mesenchymal Transition of Type Ⅱ Alveolar Epithelial Cells Induced by TGF-β1

Regulatory Mechanisms of TGF‐β1‐induced Fibrogenesis of Human Alveolar Epithelial Cells

The Effect of TGF-β1 and Smad7 Gene Transfer on the Phenotypic Changes of Rat Alveolar Epithelial Cells

[Effect of Smad7 on Transforming Growth Factor-Beta1-induced Alveolar Epithelial to Mesenchymal Transition].

YY1 Mediates TGF-β1-induced EMT and Pro-Fibrogenesis in Alveolar Epithelial Cells.

Transforming growth factor-β1 induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3K/Akt and MEK/Erk1/2 signaling pathways

Effect of TGF-β1 and EGF on the Phenotypical Change and Function of Type Ⅱ Alveolar Epithelial Cells

JNK Regulates Epithelial Mesenchymal Transition Induced by Transforming Growth Factor Β1 in Rat Peritoneal Mesothelial Cells

Alteration of mitochondrial synthesis and function in epithelial-mesenchymal transition by TGF-β1

Role of Extracellular Signal-Regulated Kinase, P38 Kinase, and Activator Protein-1 in Transforming Growth Factor- Β 1–induced Alpha Smooth Muscle Actin Expression in Human Fetal Lung Fibroblasts in Vitro

Transforming Growth Factor-Β1 Induced Epithelial-Mesenchymal Transition in Hepatic Fibrosis.

A Crosstalk Between the Smad and JNK Signaling in the TGF-β-induced Epithelial-Mesenchymal Transition in Rat Peritoneal Mesothelial Cells.

MAPKs signaling pathway is involved in transdifferentiation of airway epithelial cells into myofibroblasts induced by transforming growth factor-β1 in vitro

Ezrin is Required for Epithelial-Mesenchymal Transition Induced by TGF-β1 in A549 Cells

Therapeutic Effects of Conditioned Medium from Bone Marrow-Derived Mesenchymal Stem Cells on Epithelial-Mesenchymal Transition in A549 Cells.

Lipopolysaccharide induces epithelial–mesenchymal transition of alveolar epithelial cells cocultured with macrophages possibly via the JAK2/STAT3 signaling pathway

Integrin-linked kinase mediates CTGF-induced epithelial to mesenchymal transition in alveolar type II epithelial cells

Transforming Growth Factor-Beta 1 Induces Epithelial-To-Mesenchymal Transition In Human Lung Cancer Cells Via Pi3k/Akt And Mek/Erk1/2 Signaling Pathways